Safety Alerts & Recalls

What does this mean?

The issue has been known for some time and most physicians will have taken it into account when balancing benefit versus risk. That said, you should (a) be aware of the possibility of PML, (b) regularly balance the benefits and risks of treatment with your doctor, and (c) tell your doctor if you notice problems such as weakness in the hands or legs, difficulty thinking or concentrating, or a loss of coordination - which could be early signs of the condition.

Warnings Added To Labeling

Roche announced that information regarding the link between the use of Mycophenolate and the development of progressive multifocal leukoencephalopathy (PML), a life-threatening disease, has been added to the WARNINGS and ADVERSE REACTIONS sections of the product labeling. This is a follow-up to a previous iGuard alert sent when the FDA was reviewing this issue.

For more information, please visit: more information here

Source: Manufacturer
Publication Date: 2008-06-30
Last Updated: 2009-12-06

Visit the medication page for the following drugs:

Share your story Share your story! Tell us how MediGuard has helped you or someone you love. Mobile graphic Download the MediGuard Mobile App to manage your prescription and over-the-counter medications, for free. Registration Info Taking multiple medications puts you at risk for possible drug-drug interactions Registration Info Monitor the medical treatment of you and your loved ones.
Back to Consumer Med Safety